DE69424288T2 - Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung - Google Patents

Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung

Info

Publication number
DE69424288T2
DE69424288T2 DE69424288T DE69424288T DE69424288T2 DE 69424288 T2 DE69424288 T2 DE 69424288T2 DE 69424288 T DE69424288 T DE 69424288T DE 69424288 T DE69424288 T DE 69424288T DE 69424288 T2 DE69424288 T2 DE 69424288T2
Authority
DE
Germany
Prior art keywords
particles
production
chemical properties
modified physical
insecticides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69424288T
Other languages
English (en)
Other versions
DE69424288D1 (de
Inventor
Kirsten Westesen
Britta Siekmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mse Pharmazeutika 61352 Bad Homburg De GmbH
Original Assignee
Knoll GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll GmbH filed Critical Knoll GmbH
Priority to DE69424288T priority Critical patent/DE69424288T2/de
Application granted granted Critical
Publication of DE69424288D1 publication Critical patent/DE69424288D1/de
Publication of DE69424288T2 publication Critical patent/DE69424288T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/28—Quinones containing groups having oxygen atoms singly bound to carbon atoms with monocyclic quinoid structure
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
    • C09K23/14—Derivatives of phosphoric acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Nanotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69424288T 1993-08-12 1994-08-09 Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung Expired - Lifetime DE69424288T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE69424288T DE69424288T2 (de) 1993-08-12 1994-08-09 Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4327063A DE4327063A1 (de) 1993-08-12 1993-08-12 Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
PCT/SE1994/000728 WO1995005164A1 (en) 1993-08-12 1994-08-09 Particles with modified physicochemical properties, their preparation and uses
DE69424288T DE69424288T2 (de) 1993-08-12 1994-08-09 Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung

Publications (2)

Publication Number Publication Date
DE69424288D1 DE69424288D1 (de) 2000-06-08
DE69424288T2 true DE69424288T2 (de) 2000-10-19

Family

ID=6495011

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4327063A Withdrawn DE4327063A1 (de) 1993-08-12 1993-08-12 Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
DE69424288T Expired - Lifetime DE69424288T2 (de) 1993-08-12 1994-08-09 Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4327063A Withdrawn DE4327063A1 (de) 1993-08-12 1993-08-12 Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften

Country Status (11)

Country Link
US (1) US6197349B1 (de)
EP (1) EP0711151B1 (de)
JP (1) JPH09502963A (de)
AT (1) ATE192333T1 (de)
AU (1) AU7392694A (de)
DE (2) DE4327063A1 (de)
DK (1) DK0711151T3 (de)
ES (1) ES2145146T3 (de)
GR (1) GR3033751T3 (de)
PT (1) PT711151E (de)
WO (1) WO1995005164A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10311352A1 (de) * 2003-03-14 2004-09-23 Siemens Ag Im HE(21 delta)-Mode anregbarer Resonator

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133955A1 (en) * 1993-02-22 2003-07-17 American Bioscience, Inc. Methods and compositions useful for administration of chemotherapeutic agents
US5439686A (en) * 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US20070117862A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
DE69633222T2 (de) 1995-02-24 2005-09-08 Elan Pharma International Ltd. Nanopartikel-dispersionen enthaltende aerosole
DE19537027A1 (de) 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
WO1997030696A1 (fr) * 1996-02-26 1997-08-28 Daiichi Pharmaceutical Co., Ltd. Liposome et dispersion de liposome
US20070092563A1 (en) * 1996-10-01 2007-04-26 Abraxis Bioscience, Inc. Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
ES2159938T3 (es) * 1997-02-11 2001-10-16 Mse Pharmazeutika Gmbh Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona.
US20030199425A1 (en) * 1997-06-27 2003-10-23 Desai Neil P. Compositions and methods for treatment of hyperplasia
US8853260B2 (en) * 1997-06-27 2014-10-07 Abraxis Bioscience, Llc Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
IT1296914B1 (it) * 1997-12-01 1999-08-03 Maria Rosa Gasco Composizione farmaceutica comprendente microparticelle atte al passaggio transmucosale ed al superamento della barriera
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
DE19856432A1 (de) * 1998-12-08 2000-06-15 Basf Ag Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
DE19905880A1 (de) * 1999-02-11 2000-08-17 Mse Pharmazeutika Gmbh Spray enthaltend Ubichinon Qn
DE19905879A1 (de) * 1999-02-11 2000-08-17 Mse Pharmazeutika Gmbh Ubichinon Qn zur Behandlung von Schmerzen
US20040034107A1 (en) * 1999-02-11 2004-02-19 Mse Pharmazeutika Gmbh Ubiquinone Qn for the treatment of pain
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
DE19926168A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Stylingmittel auf Alkoholbasis mit Biochinonen
DE19926156A1 (de) * 1999-06-09 2000-12-14 Beiersdorf Ag Haarkosmetische Zubereitungen insbesondere solche zur Verbesserung der Kämmbarkeit der Haare auf der Grundlage von Ubichinonen
US6555139B2 (en) * 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
SG98393A1 (en) 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
DE10046541A1 (de) 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6403116B1 (en) 2000-11-03 2002-06-11 Triarco Inductries, Inc. Coenzyme Q10 formulation
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
EP1269994A3 (de) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmazeutische Zusammensetzungen die ein Arzneimittel und die Konzentration verbesserende Polymere enthalten
WO2003000236A1 (en) * 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc Particles with improved solubilization capacity
JP2004536136A (ja) 2001-07-27 2004-12-02 エヌ・ヴイ・ヌートリシア 敗血症の防止及び／又は処置のための経腸組成物
US20080305173A1 (en) * 2001-07-31 2008-12-11 Beuford Arlie Bogue Amorphous drug beads
AU2002323168A1 (en) 2001-09-05 2003-03-18 Rensselaer Polytechnic Institute Passivated nanoparticles, method of fabrication thereof, and devices incorporating nanoparticles
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja) 2001-09-26 2005-02-10 バクスター・インターナショナル・インコーポレイテッド 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
DE10151392A1 (de) * 2001-10-18 2003-05-08 Bayer Cropscience Ag Pulverförmige Feststoff-Formulierungen
WO2003041632A2 (en) 2001-11-14 2003-05-22 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
ES2278984T3 (es) * 2001-11-22 2007-08-16 Firmenich Sa Microcapsulas perfumantes o saborizantes que comprenden un agente ignifugo.
ATE403432T1 (de) 2002-02-01 2008-08-15 Pfizer Prod Inc Pharmazeutische darreichungsform mit gesteuerter freigabe eines cholesterylester- transferproteininhibitors
CN1633245A (zh) * 2002-02-14 2005-06-29 Dsmip资产有限公司 水可分散的辅酶q10干粉
WO2003075900A2 (de) * 2002-03-09 2003-09-18 Mse Pharmazeutika Gmbh Verwendung von ubichinonen zur beeinflussung der histaminwirkung zur behandlung von bronchitis, asthma, allergischen krankheiten
DE10214031A1 (de) * 2002-03-27 2004-02-19 Pharmatech Gmbh Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
EP1551457A1 (de) * 2002-07-16 2005-07-13 Elan Pharma International Limited Flüssige dosierzusammensetzungen von stabilen wirkstoffen in nanoteilchenform
ITMI20021725A1 (it) * 2002-08-01 2002-10-31 Zambon Spa Composizioni farmaceutiche ad attivita' antibiotica.
CA2496441C (en) 2002-08-12 2010-03-16 Pfizer Products Inc. Pharmaceutical compositions of semi-ordered drugs and polymers
AU2003299590B8 (en) 2002-12-09 2010-04-08 Abraxis Bioscience, Llc Compositions and methods of delivery of pharmacological agents
WO2004062602A2 (en) * 2003-01-09 2004-07-29 Arizeke Pharmaceuticals Inc. Compositions and methods for targeted biological delivery of molecular carriers
CN100594023C (zh) * 2003-02-03 2010-03-17 诺瓦提斯公司 药物制剂
JP2007515361A (ja) * 2003-03-06 2007-06-14 レンセラー・ポリテクニック・インスティチュート ナノ粒子の、室温におけるバルク固体からの迅速な生成
JP4481928B2 (ja) * 2003-03-11 2010-06-16 株式会社カネカ コエンザイムｑ▲１０▼を含有した水中油型乳化組成物、及びその製法
DE10312763A1 (de) * 2003-03-21 2004-09-30 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Verfahren zur Herstellung einer SLN-Dispersion
US7438903B2 (en) * 2003-06-06 2008-10-21 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
CH715855B1 (de) * 2003-08-28 2020-08-14 Mibelle Ag Zubereitung bestehend aus mindestens zwei Nanoemulsionen.
WO2005032278A1 (en) 2003-09-29 2005-04-14 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
US7713440B2 (en) * 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
MXPA06008293A (es) * 2004-01-22 2007-06-11 Univ Miami Formulaciones topicas de coenzima q10 y metodos de uso.
US7354980B1 (en) 2004-03-12 2008-04-08 Key Medical Technologies, Inc. High refractive index polymers for ophthalmic applications
WO2005095950A1 (en) * 2004-03-30 2005-10-13 Pfizer Products Inc. Method and device for evaluation of pharmaceutical compositions
US7803366B2 (en) 2004-05-07 2010-09-28 Nbty, Inc. Methods and compositions that enhance bioavailability of coenzyme-Q10
US7446157B2 (en) 2004-12-07 2008-11-04 Key Medical Technologies, Inc. Nanohybrid polymers for ophthalmic applications
NZ563946A (en) 2005-06-03 2012-02-24 Acrux Dds Pty Ltd Testosterone containing non-occlusive transdermal drug delivery composition for application to the arm pit / axilla
EP1905064A2 (de) * 2005-06-24 2008-04-02 Applied Nanoworks, Inc. Nanopartikel und verfahren zu ihrer herstellung
WO2007016435A2 (en) * 2005-07-28 2007-02-08 Isp Investments Inc. Method to improve characteristics of spray dried powders and granulated materials, and the products thereby produced
AU2006280511A1 (en) * 2005-08-12 2007-02-22 Astrazeneca Ab Process
WO2008054508A2 (en) * 2006-04-13 2008-05-08 Alza Corporation Stable nanosized amorphous drug
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
US20080181957A1 (en) * 2006-06-23 2008-07-31 Min Wei Increased amorphous stability of poorly water soluble drugs by nanosizing
US20080245769A1 (en) * 2006-07-17 2008-10-09 Applied Nanoworks, Inc. Nanoparticles and method of making thereof
WO2008065502A1 (en) * 2006-11-29 2008-06-05 Pfizer Products Inc. Pharmaceutical compositions based on a) nanoparticles comprising enteric polymers and b) casein
US20080152717A1 (en) * 2006-12-14 2008-06-26 Isp Investments, Inc. Amorphous valsartan and the production thereof
US8613946B2 (en) * 2006-12-21 2013-12-24 Isp Investment Inc. Carotenoids of enhanced bioavailability
WO2008092046A2 (en) * 2007-01-26 2008-07-31 Isp Investments Inc. Amorphous oxcarbazepine and the production thereof
CN101622302B (zh) * 2007-01-26 2013-01-23 Isp投资公司 生产喷雾干燥产品的制剂工艺方法
TW200848039A (en) * 2007-02-09 2008-12-16 Astrazeneca Ab Pharmaceutical compositions
JP2010517759A (ja) * 2007-02-09 2010-05-27 アストラゼネカ・アクチエボラーグ 水性媒体中における固体非晶質サブミクロン粒子の安定な分散体を製造する方法
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
WO2008125940A2 (en) * 2007-04-17 2008-10-23 Pfizer Products Inc. Nanoparticles comprising non-crystalline drug
WO2008135855A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135828A2 (en) * 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
US20100080852A1 (en) * 2007-05-03 2010-04-01 Ronald Arthur Beyerinck Phamaceutical composition comprising nanoparticles and casein
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
US8974827B2 (en) * 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
US20100215747A1 (en) * 2007-07-13 2010-08-26 Corey Jay Bloom Nanoparticles comprising ionizable, poorly water soluble cellulosic polymers
KR100790957B1 (ko) 2007-09-06 2008-01-04 영남대학교 산학협력단 코-엔자임 ｑ 경구용 고형제제 조성물
US9233078B2 (en) * 2007-12-06 2016-01-12 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
EP2231169B1 (de) * 2007-12-06 2016-05-04 Bend Research, Inc. Pharmazeutische zusammensetzungen mit nanopartikeln und resuspensionsmaterial
ES2403193T3 (es) 2008-02-05 2013-05-16 Laboratorios Bago S.A. Composiciones que comprenden alprazolam para el tratamiento del insomnio primario y del insomnio asociado con estados de ansiedad y procedimientos para su preparación
CA2721071C (en) 2008-04-11 2017-10-17 Cytotech Labs, Llc Methods and use of inducing apoptosis in cancer cells
JP5687187B2 (ja) * 2008-04-30 2015-03-18 シーカ・テクノロジー・アーゲー エポキシ樹脂組成物のための活性剤
WO2009135865A1 (de) * 2008-05-09 2009-11-12 Basf Se Verfahren zur herstellung von partikeln enthaltend agrochemische wirkstoffe in amorpher form
CA2730760A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
JP2012506904A (ja) 2008-10-28 2012-03-22 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 難水溶性成分のためのメソ多孔性材料賦形剤
WO2010075065A2 (en) * 2008-12-15 2010-07-01 Banner Pharmacaps, Inc. Methods for enhancing the release and absorption of water insoluble active agents
KR101066197B1 (ko) * 2009-04-06 2011-09-20 한국생명공학연구원 코엔자임 ｑ10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물
JP6081195B2 (ja) 2009-05-11 2017-02-15 バーグ エルエルシー エピメタボリックシフター、多次元細胞内分子、または環境影響因子を使用する腫瘍性障害の診断のための方法
AU2010260208B2 (en) 2009-06-16 2014-11-13 Bristol-Myers Squibb Holdings Ireland Unlimited Company Dosage forms of apixaban
KR101779910B1 (ko) 2009-10-22 2017-09-21 비쭈리 헬스 사이언스 엘엘씨 플라보노이드를 함유하는 조성물을 제조하는 방법 및 그의 사용 방법
EP2544663B1 (de) 2010-03-12 2018-01-03 Berg LLC Intravenöse formulierung aus dem coenzym q10 (coq10) und verwendungsverfahren dafür
DE102010021688A1 (de) * 2010-05-27 2011-12-01 Qineva Gmbh & Co. Kg Verfahren zur Herstellung eines micellaren Wirkstoffkonzentrats
CN103608323B (zh) 2011-04-04 2016-08-17 博格有限责任公司 治疗中枢神经系统肿瘤的方法
EP2510930A1 (de) 2011-04-15 2012-10-17 Bionanoplus, S.L. Nanopartikel mit Halbestern aus Poly(Methylvinylether-Co-Maleinsäureanhydrid) und Verwendungen davon
PE20180414A1 (es) 2011-06-17 2018-03-01 Berg Llc Composiciones farmaceuticas inhalables
WO2013090452A1 (en) 2011-12-12 2013-06-20 Orbis Biosciences, Inc. Sustained release particle formulations
US10933032B2 (en) 2013-04-08 2021-03-02 Berg Llc Methods for the treatment of cancer using coenzyme Q10 combination therapies
IL276423B2 (en) 2013-09-04 2024-05-01 Berg Llc Pharmaceutical preparations containing coenzyme Q10 for use in cancer treatment
KR101499867B1 (ko) * 2014-04-22 2015-03-06 에스케이케미칼주식회사 활성 성분 (i) 함유 조성물 및 이의 제조 방법
EP3103440A1 (de) 2015-06-12 2016-12-14 INDENA S.p.A. Feste dispersionen von coenzym q10
CN111135142A (zh) * 2020-01-16 2020-05-12 兰州大学 一种异甘草素纳米乳及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
JPS6168412A (ja) 1984-09-10 1986-04-08 Fujisawa Pharmaceut Co Ltd 医薬品の凍結乾燥方法
DE3524788A1 (de) * 1985-07-11 1987-01-22 Lentia Gmbh Stabile, intravenoes applizierbare, waessrige fettemulsion und ein verfahren zu deren herstellung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10311352A1 (de) * 2003-03-14 2004-09-23 Siemens Ag Im HE(21 delta)-Mode anregbarer Resonator

Also Published As

Publication number Publication date
DE4327063A1 (de) 1995-02-16
ES2145146T3 (es) 2000-07-01
DK0711151T3 (da) 2000-08-14
ATE192333T1 (de) 2000-05-15
US6197349B1 (en) 2001-03-06
EP0711151B1 (de) 2000-05-03
EP0711151A1 (de) 1996-05-15
DE69424288D1 (de) 2000-06-08
JPH09502963A (ja) 1997-03-25
PT711151E (pt) 2000-10-31
GR3033751T3 (en) 2000-10-31
WO1995005164A1 (en) 1995-02-23
AU7392694A (en) 1995-03-14

Similar Documents

Publication Publication Date Title
DE69424288T2 (de) Partikel mit modifizierten physikalisch-chemischen eigenschaften, ihre herstellung und verwendung
DE59209244D1 (de) Inhalationspulver und verfahren zu ihrer herstellung
IL101241A (en) Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
ATE101797T1 (de) Spritzgel-packung, verwendung und darstellung derselben.
DE69032848T2 (de) Dosierungsmittel und dessen Verwendung
DE3850823D1 (de) System zur Freisetzung von Medikamenten und dessen Herstellungsmethode.
CA2257841A1 (en) Medicinal aerosol formulations of formoterol
CA2068216A1 (en) Lipospheres for controlled delivery of substances
ATE230980T1 (de) Formulierungen mit verzögerter freisetzung zur abgabe von metoprolol über 24 stunden
BR9711856A (pt) Agentes farmacologicamente ativos estabilizados com proteìna, métodos para sua preparação e métodos para seu uso
EP1900357A3 (de) Wirkstofffreisetzungssystem für hydrophobe Wirkstoffe
AU7993800A (en) Bioadhesive nanoparticulate compositions having cationic surface stabilizers
GEP20053427B (en) Pharmaceutical Compositions Providing Enhanced Drug Concentrations
IL110993A0 (en) Stable aqueous dispersions, including pesticidal formulations, and their preparation
BG104742A (en) Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
BG106046A (en) Pharmaceutical compositions of ertythropoietin
PL308838A1 (en) Pharmaceutical preparation containing cefixim as its active substance and method of stabilising such preparations
DE3783923T2 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
DE69222295T2 (de) Pulverförmige pharmazeutische Zusammensetzung
RU94036751A (ru) Усовершенствованный пестицидный водный суспензионный концентрат и способ его приготовления
TH14341EX (th) สารอาหารหรือสูตรผสมยาสำหรับการให้สู่ร่างกายของสัตว์เคี้ยวเอื้อง
Balaraman et al. Vector abatement with Bacillus thuringiensis H-14 and Bacillus sphaericus H-5 ab: Prospects and problems encountered.
TH14341A (th) สารอาหารหรือสูตรผสมยาสำหรับการให้สู่ร่างกายของสัตว์เคี้ยวเอื้อง
NZ513186A (en) Pesticide treatment containing two pesticides from the same chemical class

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: MSE PHARMAZEUTIKA GMBH, 61352 BAD HOMBURG, DE